Shanghai Pharmaceuticals Sets Board Meeting to Approve 2025 Results and Consider Final DividendTip Ranks·Mar 18 at 05:45 AM520690-0.28%159992+1.57%
BAIYUNSHAN PH fully acquires ZMC distribution company for a consideration of 500 million RMBAASTOCKS·Dec 17, 2025 at 09:13 AM600216+8.00%600332+0.36%
Zhejiang Medicine: State Investment High-Tech plans to reduce its holdings by no more than 1% of sharesZhitong·Sep 22, 2025 at 04:49 AM600216+8.00%
Zhejiang Medicine released its semi-annual performance, with a net profit attributable to the parent company of 673 million yuan, a year-on-year increase of 113.52%Zhitong·Aug 25, 2025 at 10:16 AM600216+8.00%
Zhejiang Medicine: Completed the repurchase of 1.43% of sharesZhitong·Aug 12, 2025 at 03:27 AM600216+8.00%
Zhejiang Medicine's subsidiary, Xinchang Pharmaceutical Factory, passed the on-site inspection by the U.S. FDAZhitong·Jun 9, 2025 at 03:01 AM600216+8.00%
Zhejiang Medicine: Has repurchased 440,700 shares with a total amount of funds used of 5.8959 million yuanZhitong·May 12, 2025 at 03:57 AM600216+8.00%
Zhejiang Medicine and others invest in Shanghai to establish a biotechnology companyZhitong·May 5, 2025 at 09:23 PM600216+8.00%
Zhejiang Medicine released its 2024 annual performance, with a net profit attributable to the parent company of 1.161 billion yuan, a year-on-year increase of 170.11%Zhitong·Apr 23, 2025 at 04:13 AM600216+8.00%
Zhejiang Medicine released its first-quarter performance, with a net profit attributable to the parent company of 409 million yuan, a year-on-year increase of 273.08%Zhitong·Apr 23, 2025 at 04:11 AM600216+8.00%
Zhejiang Medicine: Plans to repurchase company shares for 100 million to 200 million yuan, with a repurchase price not exceeding 20.83 yuan per shareZhitong·Apr 18, 2025 at 03:34 AM600216+8.00%
Zhejiang Medicine has obtained a commitment letter for stock repurchase loans from financial institutionsZhitong·Apr 16, 2025 at 06:39 AM600216+8.00%
Zhejiang Medicine plans to spend 100 million to 200 million yuan to repurchase sharesZhitong·Apr 14, 2025 at 04:20 AM600216+8.00%
The chairman of ZMC proposed that the company repurchase shares for 100 million to 200 million yuanZhitong·Apr 9, 2025 at 05:22 AM600216+8.00%
The artemisinin sector sees a short-term surge, Rundu Pharma hits the limit upZhitong·Mar 26, 2025 at 09:58 PM600216+8.00%600062+0.25%
